IL-10 is generally considered an anti-inflammatory cytokine, and this may (at least partially) represent a compensatory mechanism that may have prevented DSS-induced barrier dysfunction from promoting PD-like behavior and brain pathology. The gene discussed is IL10; the disease is Parkinson disease.